Effectiveness and safety of blonanserin for improving social and cognitive functions in patients with first-episode schizophrenia: a study protocol for a prospective, multicentre, single-arm clinical trial.

Abstract

Authors

• Chengcheng Pu
  Department of Clinical Research, Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
• Lei Lei
  Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
• Fude Yang
  Psychiatry Research Center, Beijing Huilongguan Hospital, Beijing, China.
• Hong Deng
  Mental Health Center, West China Hospital of Sichuan University, Chengdu, China.
• Jianhua Sheng
  Department of Psychiatry, Shanghai Mental Health Center, Shanghai, China.
• Zhening Liu
  Mental Health Institute, the Second Xiangya Hospital of Central South University, Changsha, China.
• Shaohua Hu
  Department of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Key Laboratory of Mental Disorder's Management of Zhejiang Province, Zhejiang Engineering Center for Mathematical Mental Health, Hangzhou, Zhejiang, China.
• Lina Wang
  Department of Biochemistry and Molecular Biology, Shandong University School of MedicineJinan, P. R. China; Central Laboratory, The Second Hospital of Shandong UniversityJinan, P. R. China.
• Bin Wu
  Department of Psychiatry, Xi'an Mental Health Center, Xi'an, China.
• Qijing Bo
  Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China.
• Yoshifumi Inoue
  Medical Affairs Department, Sumitomo Dainippon Pharma Co, Osaka, Japan.
• Xin Yu
  eSep Inc., Keihanna Open Innovation Center @ Kyoto (KICK), Annex 320, 7-5-1, Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0238, Japan.

Keywords

External Resources